A New Target for DNA Repair Emerges in the Nucleus
Recent research published in *Cell Death & Differentiation* reveals a novel regulatory mechanism for non-homologous end joining (NHEJ), a critical pathway for repairing DNA double-strand breaks. The study identifies that the acetylation of the protein EXOC4 triggers its translocation into the cell nucleus. Once inside, acetylated EXOC4 regulates the methylation of KU70, a core component of the DNA repair machinery. This acetylation-dependent process directly facilitates the efficient execution of the NHEJ pathway, highlighting a previously unknown layer of post-translational control over this essential genomic maintenance system.
Study Significance: For hematologists focused on malignancies like leukemia and lymphoma, where genomic instability is a hallmark, this discovery of EXOC4’s role is significant. It identifies a new potential therapeutic target for modulating DNA repair fidelity, which could inform strategies to sensitize cancer cells to genotoxic treatments or address mechanisms of treatment resistance. Understanding this regulatory axis may also provide insights into the underlying biology of myelodysplastic syndromes and other blood disorders driven by defective DNA repair.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
